70
Participants
Start Date
July 19, 2021
Primary Completion Date
May 7, 2026
Study Completion Date
May 7, 2026
anakinra
intravenous injection of 100 milligrams anakinra
Placebo
intravenous injection of 1 milliliter normal saline
Nociceptive pain challenge
The experimental, standardized, nociceptive pain challenge will induce a moderate level of sustained pain. The pain challenge involves a masseteric injection in the left or right jaw muscle of normal saline (0.15 ml bolus of 0.9% normal saline) over a 15 second period followed by continuous infusion via a closed loop infusion system for 20 minutes.
RECRUITING
The University of Texas Health Science Center at Houston, Houston
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Alan Prossin
OTHER